Wednesday, July 8, 2026

pharma · Epidermolysis Bullosa Simplex · INM

InMed Pharmaceuticals

InMed Pharmaceuticals drug portfolio — 0 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.

Vancouver, CA HQ
19 Employees
Public company Type
INM · NYSE Ticker
Company details
Status
Public
HQ
Vancouver, CA
Employees
19
Programs
1
Drugs
0
Patents
15
Intelligence · Drug Pipeline

InMed Pharmaceuticals pipeline

Portfolio lens on 0 drugs and development assets — regulatory status, targets, and deep links to NovaPharmaNews drug profiles.

InMed Pharmaceuticals drug portfolio — 0 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.

No drugs indexed yet

We have not linked approved or pipeline drugs to this company profile yet.

View clinical projects →